Luyan Pharma Co (SZSE:002788) COGS-to-Revenue : 0.93 (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Luyan Pharma Co COGS-to-Revenue?

Luyan Pharma Co's Cost of Goods Sold for the three months ended in Mar. 2024 was ¥4,758 Mil. Its Revenue for the three months ended in Mar. 2024 was ¥5,136 Mil.

Luyan Pharma Co's COGS to Revenue for the three months ended in Mar. 2024 was 0.93.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Luyan Pharma Co's Gross Margin % for the three months ended in Mar. 2024 was 7.36%.

Luyan Pharma Co COGS-to-Revenue Historical Data

The historical data trend for Luyan Pharma Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Luyan Pharma Co COGS-to-Revenue Chart

Luyan Pharma Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.92

Luyan Pharma Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial															0.93	0.93	0.93	0.92	0.93

Luyan Pharma Co COGS-to-Revenue Calculation

Luyan Pharma Co's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	18336.471	/	19845.535
	=	0.92

Luyan Pharma Co's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	4757.525	/	5135.681
	=	0.93

Luyan Pharma Co (SZSE:002788) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Luyan Pharma Co's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	4757.525 / 5135.681
	=	7.36 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Luyan Pharma Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Luyan Pharma Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Luyan Pharma Co (SZSE:002788) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Luyan Pharma Co Ltd (SZSE:002788) » Definitions » COGS-to-Revenue

Traded in Other Exchanges

N/A

Address

1004 Ridge Road, Huli District, Fujian Province, Xiamen City, CHN, 361 010

Website

http://www.luyan.com.cn

Luyan Pharma Co Ltd, formerly Luyan (Fujian) Pharma Co Ltd engages in the production, operation, distribution, and retail of human health products in China. It provides medical and health products.

Executives

Zhu Ming Guo	Executives
Yang Cong Jin	Directors, executives
Lei Ming	Directors, executives
Li Wei Yang	Executives
Cai Mei Zhen	Supervisors
Li Cui Ping	Supervisors
Wu Jin Xiang	Directors, executives
Zhang Jun Ying	Executives
Wu Huo Lu	Director

Luyan Pharma Co (SZSE:002788) Headlines

No Headlines